stoxline Quote Chart Rank Option Currency Glossary
  
STERIS plc (STE)
232.91  1.57 (0.68%)    02-29 16:00
Open: 231.88
High: 233.495
Volume: 374,857
  
Pre. Close: 231.34
Low: 229.59
Market Cap: 23,015(M)
Technical analysis
2024-02-29 4:46:38 PM
Short term     
Mid term     
Targets 6-month :  278.57 1-year :  325.38
Resists First :  238.5 Second :  278.57
Pivot price 230.02
Supports First :  220.89 Second :  210
MAs MA(5) :  233.26 MA(20) :  228.39
MA(100) :  216.08 MA(250) :  211.94
MACD MACD :  3.7 Signal :  3.6
%K %D K(14,3) :  78 D(3) :  80.4
RSI RSI(14): 60.2
52-week High :  254 Low :  173.21
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ STE ] has closed below upper band by 34.1%. Bollinger Bands are 8.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 234.04 - 235.59 235.59 - 236.99
Low: 225.4 - 227.4 227.4 - 229.2
Close: 229.84 - 232.97 232.97 - 235.81
Company Description

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Headline News

Thu, 29 Feb 2024
Zacks Research Weighs in on STERIS plc's Q4 2024 Earnings (NYSE:STE) - MarketBeat

Thu, 29 Feb 2024
Eventide Asset Management LLC Sells 10,171 Shares of STERIS plc (NYSE:STE) - MarketBeat

Wed, 28 Feb 2024
Steris PLC stock underperforms Wednesday when compared to competitors - MarketWatch

Wed, 28 Feb 2024
Hsbc Holdings PLC Raises Stock Holdings in STERIS plc (NYSE:STE) - AmericanBankingNEWS

Tue, 27 Feb 2024
Steris PLC stock underperforms Tuesday when compared to competitors - MarketWatch

Tue, 27 Feb 2024
Here's Why Investors Should Retain STERIS (STE) Stock for Now - Zacks Investment Research

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical Devices
Shares Out 99 (M)
Shares Float 98 (M)
Held by Insiders 0.2 (%)
Held by Institutions 97.9 (%)
Shares Short 2,150 (K)
Shares Short P.Month 1,980 (K)
Stock Financials
EPS 5.67
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 64.93
Profit Margin 10.4 %
Operating Margin 15.8 %
Return on Assets (ttm) 4.7 %
Return on Equity (ttm) 9.1 %
Qtrly Rev. Growth 14.8 %
Gross Profit (p.s.) 0
Sales Per Share 54.75
EBITDA (p.s.) 14.37
Qtrly Earnings Growth 14.5 %
Operating Cash Flow 934 (M)
Levered Free Cash Flow 524 (M)
Stock Valuations
PE Ratio 41
PEG Ratio 2.7
Price to Book value 3.58
Price to Sales 4.25
Price to Cash Flow 24.63
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android